Taurus Asset Management, LLC Johnson & Johnson Transaction History

Taurus Asset Management, LLC

$984 Million
Q4 2024

A detailed history of Taurus Asset Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Taurus Asset Management, LLC holds 32,035 shares of JNJ stock, worth $5.2 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

32,035

Previous 37,195 13.87%

Holding current value

$5.2 Million

Previous $6.03 Million 23.15%

% of portfolio

0.47%

Previous 0.62%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$143.34 - $165.86 $739,634 - $855,837	-5,160 Reduced 13.87%	32,035 $4.63 Million
Q3 2024 Nov 07, 2024	BUY	$145.48 - $167.38 $7,273 - $8,369	50 Added 0.13%	37,195 $6.03 Million
Q2 2024 Aug 08, 2024	SELL	$144.38 - $157.78 $135,139 - $147,682	-936 Reduced 2.46%	37,145 $5.43 Million
Q1 2024 May 08, 2024	SELL	$155.22 - $162.74 $170,276 - $178,525	-1,097 Reduced 2.8%	38,081 $6.02 Million
Q4 2023 Feb 12, 2024	SELL	$145.6 - $158.88 $128,564 - $140,291	-883 Reduced 2.2%	39,178 $6.14 Million
Q2 2023 Aug 08, 2023	SELL	$154.35 - $166.11 $7,717 - $8,305	-50 Reduced 0.12%	40,061 $6.63 Million
Q1 2023 May 08, 2023	SELL	$151.05 - $180.26 $27,642 - $32,987	-183 Reduced 0.45%	40,111 $6.22 Million
Q4 2022 Feb 10, 2023	SELL	$160.2 - $179.79 $7,849 - $8,809	-49 Reduced 0.12%	40,294 $7.12 Million
Q3 2022 Nov 09, 2022	SELL	$161.33 - $179.52 $146,003 - $162,465	-905 Reduced 2.19%	40,343 $6.59 Million
Q2 2022 Aug 10, 2022	SELL	$168.19 - $186.01 $152,716 - $168,897	-908 Reduced 2.15%	41,248 $7.32 Million
Q1 2022 May 09, 2022	SELL	$158.14 - $179.59 $1.92 Million - $2.18 Million	-12,140 Reduced 22.36%	42,156 $7.47 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $3,898 - $4,325	-25 Reduced 0.05%	54,296 $9.29 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $75,420 - $83,812	-467 Reduced 0.85%	54,321 $8.77 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $303,012 - $325,033	1,900 Added 3.59%	54,788 $9.03 Million
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $262,515 - $292,373	-1,715 Reduced 3.14%	52,888 $8.69 Million
Q4 2020 Feb 09, 2021	SELL	$137.11 - $157.38 $801,407 - $919,886	-5,845 Reduced 9.67%	54,603 $8.59 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $140,380 - $153,830	-1,000 Reduced 1.63%	60,448 $9 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $45,083 - $54,428	-350 Reduced 0.57%	61,448 $8.64 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $38,121 - $52,818	-343 Reduced 0.55%	61,798 $8.1 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $61,837 - $71,023	-485 Reduced 0.77%	62,141 $9.07 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $94,069 - $105,325	-741 Reduced 1.17%	62,626 $8.1 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $232,791 - $256,026	-1,775 Reduced 2.72%	63,367 $8.83 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $377,034 - $419,230	-2,999 Reduced 4.4%	65,142 $9.11 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $117,189 - $141,039	954 Added 1.42%	68,141 $8.79 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $106,382 - $125,020	-875 Reduced 1.29%	67,187 $9.28 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $1,791 - $1,976	-15 Reduced 0.02%	68,062 $8.26 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $8,006 - $9,480	-64 Reduced 0.09%	68,077 $8.72 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $121,378 - $132,848	925 Added 1.38%	68,141 $9.52 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $8.7 Million - $9.1 Million	67,216	67,216 $8.74 Million

Others Institutions Holding JNJ

# of Institutions

4,509

Shares Held

1.73B

Call Options Held

16.8M

Put Options Held

13.9M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $424B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taurus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taurus Asset Management, LLC with notifications on news.

Account

Taurus Asset Management, LLC Johnson & Johnson Transaction History